Gomaa Asmaa, Gomaa Mohamed, Allam Naglaa, Waked Imam
Hepatology and Gastroenterology Department, National Liver Institute, Menofia University, Shebin El-Kom 32511, Egypt.
Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Pathogens. 2024 Aug 12;13(8):681. doi: 10.3390/pathogens13080681.
Egypt has long been overwhelmed by the hepatitis C virus (HCV) infection, and it used to be the country with the world's highest prevalence rates. The disease had been a significant public health problem, affecting millions of Egyptians and posing severe economic and social challenges. By the early 2000s, it was estimated that around 10% of the Egyptian population was infected with HCV. However, in recent years, with the availability of direct-acting antiviral therapies, the country has made enormous steps in combating this public health threat. The combination of innovative health strategies and political will enabled Egypt to establish a successful model of care for HCV management and to be the first country to eliminate hepatitis C, setting a model for the rest of the world. In 2023, Egypt became the first country to fulfill the World Health Organization's set programmatic criteria of reduction of hepatitis C incidence and mortalities to levels close to elimination of disease or achieve the "gold tier" status on the path to disease elimination.
长期以来，埃及一直深受丙型肝炎病毒（HCV）感染的困扰，它曾是全球患病率最高的国家。这种疾病曾是一个重大的公共卫生问题，影响着数百万埃及人，并带来了严峻的经济和社会挑战。到21世纪初，据估计约10%的埃及人口感染了丙型肝炎病毒。然而，近年来，随着直接抗病毒疗法的出现，该国在应对这一公共卫生威胁方面取得了巨大进展。创新的卫生策略与政治意愿相结合，使埃及建立了一个成功的丙型肝炎管理护理模式，并成为首个消除丙型肝炎的国家，为世界其他国家树立了榜样。2023年，埃及成为首个达到世界卫生组织设定的将丙型肝炎发病率和死亡率降低到接近消除疾病水平的规划标准的国家，或在疾病消除之路上达到“黄金级别”的国家。
